Keyphrases
Europe
100%
Response to Treatment
100%
Clinical Assessment
100%
Soft Tissue Infection
100%
Skin Tissue
100%
Response Assessment
100%
Oral Antibiotics
40%
Potential Impact
20%
Health Care Costs
20%
Data Reporting
20%
Clinical Decision-making
20%
Antibiotic Use
20%
Clinical Response
20%
Early Discharge
20%
Staphylococcus Aureus
20%
Clinical Trial Data
20%
Two-dose
20%
Lesion Size
20%
Current Treatment
20%
Outpatient Parenteral Antibiotic Therapy
20%
Acute Infection
20%
Intravenous to Oral Switch
20%
Inpatient Setting
20%
Treatment Paradigms
20%
Infusion Therapy
20%
Oritavancin
20%
Novel Endpoints
20%
De-escalation Therapy
20%
Emerging Therapies
20%
Tedizolid Phosphate
20%
Early Clinical Response
20%
Meticillin-resistant
20%
Dalbavancin
20%
Oral Use
20%
Medicine and Dentistry
Clinician
100%
Clinical Assessment
100%
Soft Tissue Infection
100%
Infection
40%
Antibiotic Therapy
40%
Clinical Trial
20%
Outpatient
20%
Health Care Cost
20%
Antibiotics
20%
Treatment Duration
20%
Single Drug Dose
20%
Staphylococcus Aureus
20%
Meticillin
20%
Clinical Decision Making
20%
Oritavancin
20%
Tedizolid
20%
Infusion Therapy
20%
Dalbavancin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Soft Tissue Infection
100%
Infection
40%
Antibiotic Therapy
40%
Clinical Trial
20%
Antibiotics
20%
Staphylococcus Aureus
20%
Meticillin
20%
Tedizolid
20%
Oritavancin
20%
Dalbavancin
20%